Our results suggest that diosbulbin C induces cell cycle arrest and inhibits the proliferation of NSCLC cells, possibly by downregulating the expression/activation of AKT, DHFR, and TYMS. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.